Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Illinois Wellness Insider.
Press releases published on August 25, 2025
Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension
GlobeNewswire
·
August 25, 2025
Palo Alto, CA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced today that the Paradise™ Ultrasound Renal Denervation (uRDN) system has received approval for …
NLP in Healthcare & Life Sciences Market Surges to $16.01 billion by 2030 - Dominated by Microsoft (US), Google (US), IQVIA (US)
GlobeNewswire
·
August 25, 2025
Delray Beach, FL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets™, the NLP in Healthcare …
US Rheumatologists Point to Difficult-to-Treat populations, Oral Delivery, and Novel Mechanisms as the Key Drivers of Future RA Treatment Evolution, According to Spherix Global Insights
GlobeNewswire
·
August 25, 2025
EXTON, PA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- According to the latest findings from Spherix Global Insights’ Market Dynamix™: Rheumatoid Arthritis (US) 2025, the most notable near-term disruption in the RA market stems from continued TNF biosimilar adoption …
Baylor Genetics to Showcase RNA Sequencing Breakthroughs for Rare Disease Diagnosis at 2025 AGBT Precision Health Meeting
GlobeNewswire
·
August 25, 2025
HOUSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced its participation in the 2025 Advances in Genome Biology and Technology (AGBT) Precision Health Conference, …
Husband Material Ministries Announces New Book by Drew Boa: "Outgrow Porn: Find Lasting Freedom Without Fighting an Exhausting Battle—A Man's Guide to Healing"
GlobeNewswire
·
August 25, 2025
Colorado Springs, CO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Husband Material Ministries, a leading nonprofit organization dedicated to helping men find lasting freedom from pornography, is proud to announce the release of a groundbreaking new book by its …
Immix Biopharma to Present at the Stifel 2025 Healthcare Conference
GlobeNewswire
·
August 25, 2025
Los Angeles, CA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced …
IMDX CFO Andrea James Featured in Empowered Patient Podcast on Democratizing Molecular Diagnostics
GlobeNewswire
·
August 25, 2025
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The Empowered Patient Podcast with Karen Jagoda recently featured Andrea James, Chief Financial Officer of Insight Molecular Diagnostics, Inc. (iMDx) (Nasdaq: IMDX), in an episode on “Democratizing Molecular …
The Sequoia Project Announces Detailed Agenda of Virtual Data Usability Workshop, Co-Sponsored by AHIMA
GlobeNewswire
·
August 25, 2025
VIENNA, Va., Aug. 25, 2025 (GLOBE NEWSWIRE) -- The Sequoia Project, a non-profit and trusted advocate for nationwide health IT interoperability, in partnership with the American Health Information Management Association (AHIMA), is releasing the full …
Palisade Bio Releases Virtual Investor KOL Connect Segment on FSCD and Lead Candidate PALI-2108
GlobeNewswire
·
August 25, 2025
– Moderated discussion with leading expert in Fibrostenotic Crohn's Disease (FSCD) and Inflammatory Bowel Diseases (IBD), Dr. Brian Feagan – Segment provides further insight into the need for more effective treatment options for FSCD and how PALI-2108 may …
Muscular Dystrophy Association Launches #MDAstrong Campaign in September During Historic 75th Anniversary, Kicking Off on Labor Day Weekend
GlobeNewswire
·
August 25, 2025
New York, Aug. 25, 2025 (GLOBE NEWSWIRE) -- This September, the Muscular Dystrophy Association (MDA) is launching its milestone #MDAstrong campaign during a historic moment for the organization: its 75th anniversary. The campaign reframes what it means to …
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on September 9
GlobeNewswire
·
August 25, 2025
HOUSTON, TX, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on September 9, 2025, at 4:15 p.m. ET. Attendees will gain an inside look at Nexalin’s …
Global Suppositories Market to Surpass USD 2.05 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 25, 2025
Delray Beach, FL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The global suppositories market, valued at US$1.56 billion in 2024, stood at US$1.63 billion in 2025 and is projected to advance at a resilient CAGR of 4.7% from 2025 to 2030, culminating in a forecasted …
Global Veterinary Diagnostics Market Set to Reach USD 5.36 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 25, 2025
Delray Beach, FL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The global veterinary diagnostics market, valued at US$3.42 billion in 2024, stood at US$3.68 billion in 2025 and is projected to advance at a resilient CAGR of 7.8% from 2025 to 2030, culminating in a …
PDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer
GlobeNewswire
·
August 25, 2025
Median Overall Survival (mOS) of 39.3 months in patients with CPS ≥ 1 – best published result with standard of care pembrolizumab or pembrolizumab + chemotherapy is 17.9 months* VERSATILE-003 Phase 3 trial in progress PRINCETON, N.J., Aug. 25, 2025 (GLOBE …
Safety Shot Secures $30 Million Strategic Investment From BONK Core Team and FalconX
GlobeNewswire
·
August 25, 2025
SCOTTSDALE, AZ, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”) today announced it has successfully priced a $30 million financing, anchored by a consortium of strategic investors including FalconX, the …
Biofrontera Inc. Announces Last-Patient-Out in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris
GlobeNewswire
·
August 25, 2025
Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026 Company plans FDA discussion in Q3 2026 to advance Phase 3 program and potential label expansion More than 50 million people affected by acne in US each year, …
24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets
GlobeNewswire
·
August 25, 2025
DENVER, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, revisits LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage …
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals
GlobeNewswire
·
August 25, 2025
CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …
HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market
GlobeNewswire
·
August 25, 2025
Company’s pembrolizumab-based immune checkpoint inhibitor exhibited success against solid tumors in IND-enabling studies by simultaneously activating immune cells and promoting their infiltration into solid tumors Presentation at Nova Southeastern …
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025
GlobeNewswire
·
August 25, 2025
DUBLIN and BRIDGEWATER, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced upcoming presentations at the European Society of Cardiology (ESC) Congress 2025, August 29th-September 1st, in Madrid, Spain, where new …